196 related articles for article (PubMed ID: 24619071)
21. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
[TBL] [Abstract][Full Text] [Related]
22. Uptake trends in the Scottish Bowel Screening Programme and the influences of age, sex, and deprivation.
Quyn AJ; Fraser CG; Stanners G; Carey FA; Carden C; Shaukat A; Steele RJ
J Med Screen; 2018 Mar; 25(1):24-31. PubMed ID: 29183246
[TBL] [Abstract][Full Text] [Related]
23. Inequalities in cancer screening participation: examining differences in perceived benefits and barriers.
Smith SG; McGregor LM; Raine R; Wardle J; von Wagner C; Robb KA
Psychooncology; 2016 Oct; 25(10):1168-1174. PubMed ID: 27309861
[TBL] [Abstract][Full Text] [Related]
24. Impact of changing from a guaiac faecal occult blood test to a faecal immunochemical test in a national screening programme: Results from a pilot study within the national bowel cancer screening programme in England.
Benton SC; Piggott C; Blyuss O; Li SJ; Mathews C; Carroll M; Duffy S
J Med Screen; 2021 Dec; 28(4):426-432. PubMed ID: 33983066
[TBL] [Abstract][Full Text] [Related]
25. Increasing bowel cancer screening participation: integrating population-wide, primary care and more targeted approaches.
Lofti-Jam KL; O'Reilly CL; Feng CS; Wakefield MA; Durkin S; Broun KH
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384890
[TBL] [Abstract][Full Text] [Related]
26. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.
Hughes K; Leggett B; Del Mar C; Croese J; Fairley S; Masson J; Aitken J; Clavarino A; Janda M; Stanton WR; Tong S; Newman B
Aust N Z J Public Health; 2005 Aug; 29(4):358-64. PubMed ID: 16222934
[TBL] [Abstract][Full Text] [Related]
27. Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: data from the English Bowel Cancer Screening Programme.
Bevan R; Lee TJ; Nickerson C; Rubin G; Rees CJ;
J Med Screen; 2014 Jun; 21(2):89-94. PubMed ID: 24644029
[TBL] [Abstract][Full Text] [Related]
28. Market segmentation tools provide insights into demographic variations in bowel cancer screening uptake.
Gavens L; Whiteley L; Belencsak A; Careless J; Devine S; Richmond N; Muirhead A
J Epidemiol Community Health; 2019 Aug; 73(8):778-785. PubMed ID: 31129565
[TBL] [Abstract][Full Text] [Related]
29. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.
Morris S; Baio G; Kendall E; von Wagner C; Wardle J; Atkin W; Halloran SP; Handley G; Logan RF; Obichere A; Rainbow S; Smith S; Snowball J; Raine R
Br J Cancer; 2012 Aug; 107(5):765-71. PubMed ID: 22864455
[TBL] [Abstract][Full Text] [Related]
30. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.
Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z
J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822
[TBL] [Abstract][Full Text] [Related]
31. Comparison of breast and bowel cancer screening uptake patterns in a common cohort of South Asian women in England.
Price CL; Szczepura AK; Gumber AK; Patnick J
BMC Health Serv Res; 2010 Apr; 10():103. PubMed ID: 20423467
[TBL] [Abstract][Full Text] [Related]
32. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer.
Hall NJ; Rubin GP; Dobson C; Weller D; Wardle J; Ritchie M; Rees CJ
Health Expect; 2015 Oct; 18(5):1645-57. PubMed ID: 24268129
[TBL] [Abstract][Full Text] [Related]
33. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.
Clarke N; McNamara D; Kearney PM; O'Morain CA; Shearer N; Sharp L
Prev Med; 2016 Dec; 93():198-203. PubMed ID: 27765660
[TBL] [Abstract][Full Text] [Related]
34. Including a general practice endorsement letter with the testing kit in the Bowel Cancer Screening Programme: Results of a cluster randomised trial.
Cross AJ; Myles J; Greliak P; Hackshaw A; Halloran S; Benton SC; Addison C; Chapman C; Djedovic N; Smith S; Wagner CV; Duffy SW; Raine R
J Med Screen; 2021 Dec; 28(4):419-425. PubMed ID: 33645308
[TBL] [Abstract][Full Text] [Related]
35. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
36. Exploring the decision to participate in the National Health Service Bowel Cancer Screening Programme.
Ekberg M; Callender M; Hamer H; Rogers S
Eur J Cancer Prev; 2014 Sep; 23(5):391-7. PubMed ID: 24418799
[TBL] [Abstract][Full Text] [Related]
37. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening.
Steele RJ; Kostourou I; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser C
BMJ; 2010 Oct; 341():c5531. PubMed ID: 20980376
[TBL] [Abstract][Full Text] [Related]
38. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
[TBL] [Abstract][Full Text] [Related]
39. Initial participation as a predictor for continuous participation in population-based colorectal cancer screening.
Saraste D; Öhman DJ; Sventelius M; Elfström KM; Blom J; Törnberg S
J Med Screen; 2018 Sep; 25(3):126-133. PubMed ID: 28786766
[TBL] [Abstract][Full Text] [Related]
40. Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.
Raine R; Duffy SW; Wardle J; Solmi F; Morris S; Howe R; Kralj-Hans I; Snowball J; Counsell N; Moss S; Hackshaw A; von Wagner C; Vart G; McGregor LM; Smith SG; Halloran S; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Atkin W
Br J Cancer; 2016 Feb; 114(3):321-6. PubMed ID: 26742011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
